These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 14607450)
21. Relatively benign clinical course in asymptomatic patients with brugada-type electrocardiogram without family history of sudden death. Takenaka S; Kusano KF; Hisamatsu K; Nagase S; Nakamura K; Morita H; Matsubara H; Emori T; Ohe T J Cardiovasc Electrophysiol; 2001 Jan; 12(1):2-6. PubMed ID: 11204079 [TBL] [Abstract][Full Text] [Related]
22. Effect of sodium channel blocker, pilsicainide hydrochloride, on net inward current of atrial myocytes in thyroid hormone toxicosis rats. Yamakawa M; Sunagawa M; Shimabukuro M; Higa N; Takasu N; Kosugi T Thyroid; 2005 Jul; 15(7):653-9. PubMed ID: 16053380 [TBL] [Abstract][Full Text] [Related]
23. Pilsicainide-induced coronary vasospasm in a patient with Brugada-type electrocardiogram. Goda A; Yamashita T; Kato T; Koike A; Sagara K; Kirigaya H; Itoh H; Aizawa T; Fu LT Circ J; 2005 Jul; 69(7):858-60. PubMed ID: 15988113 [TBL] [Abstract][Full Text] [Related]
25. [Brugada syndrome associated with ventricular fibrillation induced by administration of pilsicainide: a case report]. Matsumoto K; Sumita S; Ishikawa T; Matsushita K; Kobayashi T; Ohkusu Y; Yamakawa Y; Nakagawa T; Nakazawa I; Mochida Y; Ebina T; Uchino K; Kimura K; Umemura S J Cardiol; 2003 Nov; 42(5):227-34. PubMed ID: 14658412 [TBL] [Abstract][Full Text] [Related]
26. Effects of the NA+ channel blocker pilsicainide on the electrophysiologic properties of pulmonary veins in patients with atrial fibrillation. Kumagai K; Tojo H; Noguchi H; Yasuda T; Ogawa M; Nakashima H; Zhang B; Saku K J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1396-401. PubMed ID: 15610286 [TBL] [Abstract][Full Text] [Related]
27. Effect of pilsicainide on atrial electrophysiologic properties in the canine rapid atrial stimulation model. Kojima J; Niwano S; Moriguchi M; Ikeda K; Inuo K; Saito J; Izumi T Circ J; 2003 Apr; 67(4):340-6. PubMed ID: 12655166 [TBL] [Abstract][Full Text] [Related]
28. Different effect of the pure Na+ channel-blocker pilsicainide on the ST-segment response in the right precordial leads in patients with normal left ventricular function. Ueyama T; Shimizu A; Yamagata T; Esato M; Ohmura M; Yoshiga Y; Kanemoto M; Kametani R; Sawa A; Suzuki S; Sugi N; Matsuzaki M Circ J; 2007 Jan; 71(1):57-62. PubMed ID: 17186979 [TBL] [Abstract][Full Text] [Related]
29. Enhancement of J-ST-segment elevation by the glucose and insulin test in Brugada syndrome. Nogami A; Nakao M; Kubota S; Sugiyasu A; Doi H; Yokoyama K; Yumoto K; Tamaki T; Kato K; Hosokawa N; Sagai H; Nakamura H; Nitta J; Yamauchi Y; Aonuma K Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):332-7. PubMed ID: 12687840 [TBL] [Abstract][Full Text] [Related]
30. What variables were associated with the inducibility of ventricular fibrillation during electrophysiologic stimulation test in patients without apparent organic heart disease? Sugi N; Shimizu A; Ueyama T; Yoshiga Y; Doi M; Ohmiya T; Ohno M; Yoshida M; Matsuzaki M J Cardiol; 2010 Jul; 56(1):35-43. PubMed ID: 20350514 [TBL] [Abstract][Full Text] [Related]
31. Class I antiarrhythmic drug and coronary vasospasm-induced T wave alternans and ventricular tachyarrhythmia in a patient with Brugada syndrome and vasospastic angina. Chinushi Y; Chinushi M; Toida T; Aizawa Y J Cardiovasc Electrophysiol; 2002 Feb; 13(2):191-4. PubMed ID: 11900298 [TBL] [Abstract][Full Text] [Related]
32. Determination of refractory periods and conduction velocity during atrial fibrillation using atrial capture in dogs: direct assessment of the wavelength and its modulation by a sodium channel blocker, pilsicainide. Shinagawa K; Mitamura H; Takeshita A; Sato T; Kanki H; Takatsuki S; Ogawa S J Am Coll Cardiol; 2000 Jan; 35(1):246-53. PubMed ID: 10636287 [TBL] [Abstract][Full Text] [Related]
33. Repolarization heterogeneity in the right ventricular outflow tract: correlation with ventricular arrhythmias in Brugada patients and in an in vitro canine Brugada model. Morita H; Zipes DP; Fukushima-Kusano K; Nagase S; Nakamura K; Morita ST; Ohe T; Wu J Heart Rhythm; 2008 May; 5(5):725-33. PubMed ID: 18452878 [TBL] [Abstract][Full Text] [Related]
34. Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome. Kakihara J; Takagi M; Hayashi Y; Tatsumi H; Doi A; Yoshiyama M Heart Vessels; 2017 Sep; 32(9):1151-1159. PubMed ID: 28364267 [TBL] [Abstract][Full Text] [Related]
35. ST segment elevation in the right precordial leads following administration of class Ic antiarrhythmic drugs. Yasuda M; Nakazato Y; Yamashita H; Sekita G; Kawano Y; Mineda Y; Nakazato K; Tokano T; Sumiyoshi M; Nakata Y Heart; 2001 Jan; 85(1):E3. PubMed ID: 11119481 [TBL] [Abstract][Full Text] [Related]
36. Are all sodium channel blockers created equal? Clinical-basic correlations based on observations in Brugada syndrome. Nattel S Heart Rhythm; 2005 Mar; 2(3):261-2. PubMed ID: 15851315 [No Abstract] [Full Text] [Related]
37. Effect of oral beta-blocker therapy on microvolt T-wave alternans and electrophysiology testing in patients with ischemic cardiomyopathy. Zacks ES; Morin DP; Ageno S; Janik M; Mauer AC; Markowitz SM; Mittal S; Iwai S; Shah BK; Lerman BB; Stein KM Am Heart J; 2007 Mar; 153(3):392-7. PubMed ID: 17307418 [TBL] [Abstract][Full Text] [Related]
38. Right bundle branch block and coved-type ST-segment elevation mimicked by acute cholecystitis. Furuhashi M; Uno K; Satoh S; Hoshikawa K; Sakai E; Tsuchihashi K; Shimamoto K Circ J; 2003 Sep; 67(9):802-4. PubMed ID: 12939560 [TBL] [Abstract][Full Text] [Related]
40. Right coronary cusp as a new window of ablation for pilsicainide-induced ventricular premature contractions in a patient with Brugada syndrome. Yamasaki H; Tada H; Sekiguchi Y; Aonuma K Heart Vessels; 2016 Aug; 31(8):1397-401. PubMed ID: 26510553 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]